title: Stereoacuity in children with anisometropic amblyopia.
abstract: OBJECTIVE
  To determine factors associated with pretreatment and posttreatment stereoacuity in subjects with moderate anisometropic amblyopia.
  
  
  METHODS
  Data for subjects enrolled in seven studies conducted by the Pediatric Eye Disease Investigator Group were pooled. The sample included 633 subjects aged 3 to <18 years with anisometropic amblyopia, no heterotropia observed by cover test, and baseline amblyopic eye acuity of 20/100 or better. A subset included 248 subjects who were treated with patching or Bangerter filters and had stereoacuity testing at both the baseline and outcome examinations. Multivariate regression models identified factors associated with baseline stereoacuity and with outcome stereoacuity as measured by the Randot Preschool Stereoacuity test.
  
  
  RESULTS
  Better baseline stereoacuity was associated with better baseline amblyopic eye acuity (P < 0.001), less anisometropia (P = 0.03), and anisometropia due to astigmatism alone (P < 0.001). Better outcome stereoacuity was associated with better baseline stereoacuity (P < 0.001) and better amblyopic eye acuity at outcome (P < 0.001). Among 48 subjects whose amblyopic eye visual acuity at outcome was 20/25 or better and within one line of the fellow eye, stereoacuity was worse than that of children with normal vision of the same age.
  
  
  CONCLUSIONS
  In children with anisometropic amblyopia of 20/40 to 20/100 inclusive, better posttreatment stereoacuity is associated with better baseline stereoacuity and better posttreatment amblyopic eye acuity. Even if their visual acuity deficit resolves, many children with anisometropic amblyopia have stereoacuity worse than that of nonamblyopic children of the same age.
authors: Duke University Eye Center, Durham, NC, USA. pedig@jaeb.org
authors: David K
authors: DK
authors: Wallace
authors: Elizabeth L
authors: EL
authors: Lazar
authors: Michele
authors: M
authors: Melia
authors: Eileen E
authors: EE
authors: Birch
authors: Jonathan M
authors: JM
authors: Holmes
authors: Kristine B
authors: KB
authors: Hopkins
authors: Raymond T
authors: RT
authors: Kraker
authors: Marjean T
authors: MT
authors: Kulp
authors: Yi
authors: Y
authors: Pang
authors: Michael X
authors: MX
authors: Repka
authors: Susanna M
authors: SM
authors: Tamkins
authors: Katherine K
authors: KK
authors: Weise
mesh_terms: D000293:Adolescent; D000550:Amblyopia / Q000150:complications / Q000628:therapy*; D015858:Anisometropia / Q000150:complications; D001251:Astigmatism / Q000150:complications; D001285:Atropine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D015337:Multicenter Studies as Topic; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012683:Sensory Deprivation; D016896:Treatment Outcome; D015348:Vision, Binocular / Q000502:physiology*; D014792:Visual Acuity / Q000502:physiology*
chemical_list: D018727:Muscarinic Antagonists; D001285:Atropine